Multi-omics sequencing of childhood hepatoblastoma and lung metastasis

Single-cell sequencing and spatial transcriptomic studies of childhood hepatoblastoma and lung metastases

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100047948

Enrollment

Unknown

Registered

2021-06-28

Start date

2022-01-01

Completion date

Unknown

Last updated

2022-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatoblastoma

Interventions

case series:None

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1. Hepatoblastoma diagnosed by imaging or confirmed by biopsy; 2. Have surgical indications for surgical treatment; 3. Can tolerate anesthesia and surgery; 4. May be associated with pulmonary metastasis associated with hepatoblastoma.

Exclusion criteria

Exclusion criteria: Tumor metastases beyond the liver and lungs.

Design outcomes

Primary

Measure	Time frame
Outcome and prognosis;	—

Countries

China

Contacts

Public ContactWang Xianqiang

The Seventh Medical Center of the Chinese People's Liberation Army General Hospital

wxq301@gmail.com+86 13522891848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026